Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro

Toll-like receptor 9 (TLR9) is a cellular DNA-receptor widely expressed in cancers. We previously showed that synthetic and self-derived DNA fragments induce TLR9-mediated breast cancer cell invasion in vitro. We investigated here the invasive effects of two nuclease-resistant DNA fragments, a 9-mer...

Full description

Saved in:
Bibliographic Details
Published inBreast cancer research and treatment Vol. 155; no. 2; pp. 261 - 271
Main Authors Tuomela, Johanna M., Sandholm, Jouko A., Kaakinen, Mika, Hayden, Katherine L., Haapasaari, Kirsi-Maria, Jukkola-Vuorinen, Arja, Kauppila, Joonas H., Lehenkari, Petri P., Harris, Kevin W., Graves, David E., Selander, Katri S.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.01.2016
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Toll-like receptor 9 (TLR9) is a cellular DNA-receptor widely expressed in cancers. We previously showed that synthetic and self-derived DNA fragments induce TLR9-mediated breast cancer cell invasion in vitro. We investigated here the invasive effects of two nuclease-resistant DNA fragments, a 9-mer hairpin, and a G-quadruplex DNA based on the human telomere sequence, both having native phosphodiester backbone. Cellular uptake of DNAs was investigated with immunofluorescence, invasion was studied with Matrigel-assays, and mRNA and protein expression were studied with qPCR and Western blotting and protease activity with zymograms. TLR9 expression was suppressed through siRNA. Although both DNAs induced TLR9-mediated changes in pro-invasive mRNA expression, only the telomeric G-quadruplex DNA significantly increased cellular invasion. This was inhibited with GM6001 and aprotinin, suggesting MMP- and serine protease mediation. Furthermore, complexing with LL-37, a cathelicidin-peptide present in breast cancers, increased 9-mer hairpin and G-quadruplex DNA uptake into the cancer cells. However, DNA/LL-37 complexes decreased invasion, as compared with DNA-treatment alone. Invasion studies were conducted also with DNA fragments isolated from neoadjuvant chemotherapy-treated breast tumors. Also such DNA induced breast cancer cell invasion in vitro. As with the synthetic DNAs, this invasive effect was reduced by complexing the neoadjuvant tumor-derived DNAs with LL-37. We conclude that 9-mer hairpin and G-quadruplex DNA fragments are nuclease-resistant DNA structures that can act as invasion-inducing TLR9 ligands. Their cellular uptake and the invasive effects are regulated via LL-37. Although such structures may be present in chemotherapy-treated tumors, the clinical significance of this finding requires further studying.
AbstractList Toll-like receptor 9 (TLR9) is a cellular DNA-receptor widely expressed in cancers. We previously showed that synthetic and self-derived DNA fragments induce TLR9-mediated breast cancer cell invasion in vitro. We investigated here the invasive effects of two nuclease-resistant DNA fragments, a 9-mer hairpin, and a G-quadruplex DNA based on the human telomere sequence, both having native phosphodiester backbone. Cellular uptake of DNAs was investigated with immunofluorescence, invasion was studied with Matrigel-assays, and mRNA and protein expression were studied with qPCR and Western blotting and protease activity with zymograms. TLR9 expression was suppressed through siRNA. Although both DNAs induced TLR9-mediated changes in pro-invasive mRNA expression, only the telomeric G-quadruplex DNA significantly increased cellular invasion. This was inhibited with GM6001 and aprotinin, suggesting MMP- and serine protease mediation. Furthermore, complexing with LL-37, a cathelicidin-peptide present in breast cancers, increased 9-mer hairpin and G-quadruplex DNA uptake into the cancer cells. However, DNA/LL-37 complexes decreased invasion, as compared with DNA-treatment alone. Invasion studies were conducted also with DNA fragments isolated from neoadjuvant chemotherapy-treated breast tumors. Also such DNA induced breast cancer cell invasion in vitro. As with the synthetic DNAs, this invasive effect was reduced by complexing the neoadjuvant tumor-derived DNAs with LL-37. We conclude that 9-mer hairpin and G-quadruplex DNA fragments are nuclease-resistant DNA structures that can act as invasion-inducing TLR9 ligands. Their cellular uptake and the invasive effects are regulated via LL-37. Although such structures may be present in chemotherapy-treated tumors, the clinical significance of this finding requires further studying.
Audience Academic
Author Kauppila, Joonas H.
Jukkola-Vuorinen, Arja
Graves, David E.
Sandholm, Jouko A.
Lehenkari, Petri P.
Selander, Katri S.
Tuomela, Johanna M.
Kaakinen, Mika
Hayden, Katherine L.
Haapasaari, Kirsi-Maria
Harris, Kevin W.
Author_xml – sequence: 1
  givenname: Johanna M.
  surname: Tuomela
  fullname: Tuomela, Johanna M.
  organization: Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, University of Alabama at Birmingham, Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku
– sequence: 2
  givenname: Jouko A.
  surname: Sandholm
  fullname: Sandholm, Jouko A.
  organization: Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, University of Alabama at Birmingham, Turku Centre for Biotechnology, University of Turku and Åbo Akademi University
– sequence: 3
  givenname: Mika
  surname: Kaakinen
  fullname: Kaakinen, Mika
  organization: Department of Anatomy and Cell Biology, University of Oulu, Oulu Center for Cell–Matrix Research, Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu
– sequence: 4
  givenname: Katherine L.
  surname: Hayden
  fullname: Hayden, Katherine L.
  organization: Department of Chemistry, University of Alabama at Birmingham
– sequence: 5
  givenname: Kirsi-Maria
  surname: Haapasaari
  fullname: Haapasaari, Kirsi-Maria
  organization: Department of Pathology, University of Oulu
– sequence: 6
  givenname: Arja
  surname: Jukkola-Vuorinen
  fullname: Jukkola-Vuorinen, Arja
  organization: Department of Oncology, University Hospital of Oulu
– sequence: 7
  givenname: Joonas H.
  surname: Kauppila
  fullname: Kauppila, Joonas H.
  organization: Department of Anatomy and Cell Biology, University of Oulu, Department of Pathology, University of Oulu, Department of Surgery, Oulu University Hospital
– sequence: 8
  givenname: Petri P.
  surname: Lehenkari
  fullname: Lehenkari, Petri P.
  organization: Department of Anatomy and Cell Biology, University of Oulu, Department of Pathology, University of Oulu, Department of Surgery, Oulu University Hospital
– sequence: 9
  givenname: Kevin W.
  surname: Harris
  fullname: Harris, Kevin W.
  organization: Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham Veterans Affairs Medical Center, Birmingham
– sequence: 10
  givenname: David E.
  surname: Graves
  fullname: Graves, David E.
  organization: Comprehensive Cancer Center, University of Alabama at Birmingham, Department of Chemistry, University of Alabama at Birmingham
– sequence: 11
  givenname: Katri S.
  surname: Selander
  fullname: Selander, Katri S.
  email: Katriselander@uabmc.edu
  organization: Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, University of Alabama at Birmingham, Department of Pathology, Lapland Central Hospital, Department of Chemistry, UAB
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26780557$$D View this record in MEDLINE/PubMed
BookMark eNqNkt9rFDEQx4NU7PX0D_BFAoL4kppfu8k-HrVW4VCQ8znkktlrym72muwWfenfbtar2oqC5CFh5jNf8p2ZE3QUhwgIPWf0lFGq3mRGK9kQymoiai1I9QgtWKUEUZypI7QoCUVqTetjdJLzFaW0UbR5go55rTStKrVAtxvohh5ScPiCXE_Wp2nfwVfSDqkPcYffflzhNtldD3HMOEQ_OcCb9eeG9OCDHcFjGz1er4lQJMFu6n7EQryxOQyxPPA2gc0jdjY6SNhB181C-CaMaXiKHre2y_Ds7l6iL-_ON2fvyfrTxYez1Zq4Ymck2nLLueTFVyNgSystBLPea6iaSkvPqWOV09wJz9qtU6ClcpWVwHnDPBNiiV4fdPdpuJ4gj6YPef6KjTBM2TClhBa0NOU_0JrJqtFyRl_-gV4NU4rFyExRxTmV6je1sx2YENthTNbNomYlJdeNnIe3RKd_ocrx0AdX5t6GEn9Q8OpewSXYbrzMQzeNpe35IcgOoEtDzglas0-ht-mbYdTMe2QOe2TKupi5wMzOXtw5m7Zl0L8qfi5OAfgByCUVd5DuWf-n6nfigNB0
CODEN BCTRD6
CitedBy_id crossref_primary_10_1080_07391102_2018_1523748
crossref_primary_10_3390_cells12010152
crossref_primary_10_3390_ijms22052671
crossref_primary_10_1016_j_ijpharm_2021_120891
crossref_primary_10_1016_j_lfs_2022_120651
crossref_primary_10_1155_2024_1111551
crossref_primary_10_3390_biom10020249
crossref_primary_10_3390_ijms17050726
crossref_primary_10_18632_oncotarget_13570
crossref_primary_10_1016_j_freeradbiomed_2019_07_019
crossref_primary_10_3390_pharmaceutics14122686
Cites_doi 10.1016/j.chom.2012.02.002
10.1111/apm.12016
10.1002/pros.20562
10.1111/jop.12160
10.1074/jbc.M311440200
10.1111/j.1365-2249.2004.02464.x
10.1111/cmi.12061
10.1002/mc.20496
10.1186/bcr2221
10.1111/j.1365-2559.2011.03991.x
10.1016/S0165-2478(02)00228-6
10.1186/1465-9921-6-1
10.1093/nar/13.21.7663
10.4049/jimmunol.171.6.3154
10.1093/nar/gkl1057
10.3389/fimmu.2014.00200
10.1093/nar/gkm1138
10.4049/jimmunol.173.2.1179
10.1159/000151602
10.1074/jbc.M206818200
10.1002/ijc.20795
10.1111/j.1523-1747.2003.12630.x
10.1158/1541-7786.MCR-06-0007
10.1007/s10549-012-2181-7
10.1074/jbc.M311618200
10.1615/CritRevImmunol.v26.i6.50
10.1016/j.ijmm.2005.02.009
10.1002/pros.21115
10.1093/nar/gkl529
10.1186/1756-9966-30-84
10.1002/ijc.23186
10.1146/annurev.immunol.22.012703.104514
10.1021/ac0517601
10.1016/j.it.2004.04.011
10.1158/1541-7786.MCR-07-2005
10.1007/s00441-010-1017-1
10.1093/nar/gkp740
10.1093/nar/22.12.2217
10.1158/1541-7786.MCR-08-0326
10.2147/JIR.S61365
10.1146/annurev.immunol.20.100301.06484201.064842
10.3233/BD-2007-26105
10.1016/j.urolonc.2014.09.016
10.4049/jimmunol.0902305
10.4049/jimmunol.1200898
10.1074/jbc.M110.159590
10.3892/ol.2014.2095
10.1089/nat.2012.0340
10.1111/j.1349-7006.2010.01491.x
10.1007/s10549-013-2762-0
ContentType Journal Article
Copyright Springer Science+Business Media New York 2016
COPYRIGHT 2016 Springer
Copyright_xml – notice: Springer Science+Business Media New York 2016
– notice: COPYRIGHT 2016 Springer
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7TO
7X7
7XB
88E
8AO
8C1
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
K9-
K9.
M0R
M0S
M1P
M2O
MBDVC
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
7TM
DOI 10.1007/s10549-016-3683-5
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database (Proquest)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Family Health Database (Proquest)
Health & Medical Collection (Alumni Edition)
Medical Database
Research Library
Research Library (Corporate)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
Nucleic Acids Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
Nucleic Acids Abstracts
DatabaseTitleList Nucleic Acids Abstracts


MEDLINE
Research Library Prep

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-7217
EndPage 271
ExternalDocumentID 3934990691
A442894368
10_1007_s10549_016_3683_5
26780557
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Feature
GrantInformation_xml – fundername: Cancer Foundation of South-Western Finland
– fundername: Maud Kuistila memorial foundation
– fundername: Congressionally Directed Medical Research Programs (US)
  grantid: W81XWH-10-1-0308
  funderid: http://dx.doi.org/10.13039/100000090
– fundername: Varsinais-Suomen Rahasto (FI)
  funderid: http://dx.doi.org/10.13039/501100005424
– fundername: Orion-Farmos Research Foundation
– fundername: Albin Johansson Foundation
– fundername: Finnish Cancer Organisations
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-XW
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
23N
28-
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3O-
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6NX
78A
7X7
88E
8AO
8C1
8FI
8FJ
8G5
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHVE
ACHXU
ACIGE
ACIHN
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACTTH
ACUDM
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEAQA
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFDYV
AFEXP
AFFNX
AFJLC
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKNYI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GRRUI
GUQSH
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
ICW
IHE
IHR
IHW
IJ-
IKXTQ
IMOTQ
INH
INR
ITC
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
K9-
KDC
KOV
KOW
KPH
LAK
LLZTM
M0R
M1P
M2O
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UDS
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z7W
Z7X
Z81
Z82
Z83
Z87
Z8O
Z8Q
Z8U
Z8V
Z8W
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~EX
~KM
AACDK
AAEOY
AAJBT
AASML
AAYZH
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
AJOOF
ALIPV
CGR
CUY
CVF
ECM
EIF
H13
NPM
AAYXX
ABQSL
CITATION
7TO
7XB
8FK
H94
K9.
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
7TM
ID FETCH-LOGICAL-c573t-8a2a224272193eb058331add8e59584d20c15c82c3d1fbc7e847c5a4e2291d133
IEDL.DBID 8C1
ISSN 0167-6806
IngestDate Fri Oct 25 20:59:48 EDT 2024
Fri Oct 25 03:15:24 EDT 2024
Mon Nov 25 06:11:52 EST 2024
Tue Nov 19 21:08:38 EST 2024
Tue Nov 12 22:53:05 EST 2024
Tue Aug 20 22:13:50 EDT 2024
Fri Dec 06 02:24:18 EST 2024
Wed Oct 16 00:45:39 EDT 2024
Sat Dec 16 12:01:01 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords 9-mer hairpin DNA
LL-37
Toll-like receptor 9
Invasion
Telomeric G-quadruplex DNA
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c573t-8a2a224272193eb058331add8e59584d20c15c82c3d1fbc7e847c5a4e2291d133
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 26780557
PQID 1760722047
PQPubID 36266
PageCount 11
ParticipantIDs proquest_miscellaneous_1773830805
proquest_miscellaneous_1761459845
proquest_journals_1760722047
gale_infotracmisc_A442894368
gale_infotracacademiconefile_A442894368
gale_healthsolutions_A442894368
crossref_primary_10_1007_s10549_016_3683_5
pubmed_primary_26780557
springer_journals_10_1007_s10549_016_3683_5
PublicationCentury 2000
PublicationDate 2016-01-01
PublicationDateYYYYMMDD 2016-01-01
PublicationDate_xml – month: 01
  year: 2016
  text: 2016-01-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: Netherlands
– name: Dordrecht
PublicationTitle Breast cancer research and treatment
PublicationTitleAbbrev Breast Cancer Res Treat
PublicationTitleAlternate Breast Cancer Res Treat
PublicationYear 2016
Publisher Springer US
Springer
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer
– name: Springer Nature B.V
References Schreiber, Koch, Neubert (CR26) 1985; 13
Yoshizawa, Ueda, Ishido, Miura, Watanabe, Hirao (CR30) 1994; 22
Mempel, Voelcker, Kollisch, Plank, Rad, Gerhard, Schnopp, Fraunberger, Walli, Ring, Abeck, Ollert (CR44) 2003; 121
Akira, Hemmi (CR1) 2003; 85
Marshak-Rothstein, Rifkin (CR40) 2007; 25
Ronkainen, Hirvikoski, Kauppila, Vuopala, Paavonen, Selander, Vaarala (CR10) 2011; 30
Trieu, Roberts, Dunn, Sweet, Stacey (CR52) 2006; 26
Merrell, Ilvesaro, Lehtonen, Sorsa, Gehrs, Rosenthal, Chen, Shackley, Harris, Selander (CR15) 2006; 4
Sandholm, Tuomela, Kauppila, Harris, Graves, Selander (CR45) 2014; 8
Nishiya, DeFranco (CR7) 2004; 279
Kauppila, Karttunen, Saarnio, Nyberg, Salo, Graves, Lehenkari, Selander (CR25) 2013; 121
Mukherjee, Siddiqui, Dayal, Ayoub, Malathi (CR22) 2014; 7
Weber, Chamorro, Granath, Liljegren, Zreika, Saidak, Sandstedt, Rotstein, Mentaverri, Sanchez, Pivarcsi, Stahle (CR51) 2009; 11
Cao, Huang, Tan (CR31) 2006; 78
Krieg (CR43) 2012; 22
Kauppila, Selander (CR41) 2014; 5
Ilvesaro, Merrell, Swain, Davidson, Zayzafoon, Harris, Selander (CR12) 2007; 67
Coffelt, Waterman, Florez, Honer zu Bentrup, Zwezdaryk, Tomchuck, LaMarca, Danka, Morris, Scandurro (CR38) 2008; 122
Silva, Dominguez, Garcia, Gonzalez, Villanueva, Navarro, Provencio, San Martin, Espana, Bonilla (CR48) 1999; 59
Fernando, Sewitz, Darot, Tavare, Huppert, Balasubramanian (CR34) 2009; 37
Chiang, Engel, Opaluch, Ramos, Maestre, Secundino, De Jesus, Nguyen, Welch, Bonamy, Miraglia, Orth, Nizet, Fernandez-Sesma, Zhou, Barton, Chanda (CR46) 2012; 11
CR49
Berger, Fiegl, Goebel, Obexer, Ausserlechner, Doppler, Hauser-Kronberger, Reitsamer, Egle, Reimer, Muller-Holzner, Jones, Widschwendter (CR20) 2010
Hidmark, von Saint Paul, Dalpke (CR4) 2012
Eddy, Maizels (CR36) 2008; 36
Chaudary, Hill (CR39) 2006; 26
Eddy, Maizels (CR33) 2006; 34
Wagner (CR2) 2004; 25
Huppert, Balasubramanian (CR35) 2007; 35
Krieg (CR27) 2002; 20
Kulkarni, Behboudi, Sharif (CR11) 2011; 343
Tuomela, Sandholm, Kaakinen, Patel, Kauppila, Ilvesaro, Chen, Harris, Graves, Selander (CR28) 2013
Heilborn, Nilsson, Jimenez, Sandstedt, Borregaard, Tham, Sorensen, Weber, Stahle (CR50) 2005; 114
Schmausser, Andrulis, Endrich, Lee, Josenhans, Muller-Hermelink, Eck (CR8) 2004; 136
Leifer, Kennedy, Mazzoni, Lee, Kruhlak, Segal (CR9) 2004; 173
Eddy, Maizels (CR32) 2009; 48
Berke, Li, Modis (CR3) 2013; 15
Ramirez, Carracedo, Jimenez, Canela, Herrera, Aljama, Blasco (CR47) 2003; 278
Droemann, Albrecht, Gerdes, Ulmer, Branscheid, Vollmer, Dalhoff, Zabel, Goldmann (CR42) 2005; 6
Korvala, Harjula, Siirila, Almangush, Aro, Makitie, Grenman, Karttunen, Leivo, Kauppila, Salo (CR18) 2014; 43
Sandgren, Wittrup, Cheng, Jonsson, Eklund, Busch, Belting (CR29) 2004; 279
Coffelt, Tomchuck, Zwezdaryk, Danka, Scandurro (CR37) 2009; 7
Schmausser, Andrulis, Endrich, Muller-Hermelink, Eck (CR13) 2005; 295
Tuomela, Sandholm, Karihtala, Ilvesaro, Vuopala, Kauppila, Kauppila, Chen, Pressey, Harkonen, Harris, Graves, Auvinen, Soini, Jukkola-Vuorinen, Selander (CR21) 2012; 135
Kauppila, Takala, Selander, Lehenkari, Saarnio, Karttunen (CR16) 2011; 59
Matsumoto, Funami, Tanabe, Oshiumi, Shingai, Seto, Yamamoto, Seya (CR6) 2003; 171
Ilvesaro, Merrell, Li, Wakchoure, Graves, Brooks, Rahko, Jukkola-Vuorinen, Vuopala, Harris, Selander (CR24) 2008; 6
CR23
Shi, Cai, Sanchez, Zhang, Wen, Wang, Yang, Fu, Zhang (CR5) 2011
Droemann, Albrecht, Gerdes, Ulmer, Branscheid, Vollmer, Dalhoff, Zabel, Goldmann (CR14) 2005; 6
Jukkola-Vuorinen, Rahko, Vuopala, Desmond, Lehenkari, Harris, Selander (CR19) 2009; 1
Vaisanen, Vaisanen, Jukkola-Vuorinen, Vuopala, Desmond, Selander, Vaarala (CR17) 2010; 70
JH Kauppila (3683_CR25) 2013; 121
H Wagner (3683_CR2) 2004; 25
AM Krieg (3683_CR27) 2002; 20
J Tuomela (3683_CR28) 2013
J Eddy (3683_CR32) 2009; 48
S Mukherjee (3683_CR22) 2014; 7
J Sandholm (3683_CR45) 2014; 8
M Matsumoto (3683_CR6) 2003; 171
R Berger (3683_CR20) 2010
D Droemann (3683_CR42) 2005; 6
3683_CR23
T Nishiya (3683_CR7) 2004; 279
SB Coffelt (3683_CR38) 2008; 122
JM Ilvesaro (3683_CR12) 2007; 67
CA Leifer (3683_CR9) 2004; 173
J Eddy (3683_CR33) 2006; 34
IC Berke (3683_CR3) 2013; 15
Z Shi (3683_CR5) 2011
MR Vaisanen (3683_CR17) 2010; 70
G Schreiber (3683_CR26) 1985; 13
CY Chiang (3683_CR46) 2012; 11
JM Ilvesaro (3683_CR24) 2008; 6
H Fernando (3683_CR34) 2009; 37
N Chaudary (3683_CR39) 2006; 26
S Sandgren (3683_CR29) 2004; 279
R Ramirez (3683_CR47) 2003; 278
B Schmausser (3683_CR8) 2004; 136
JH Kauppila (3683_CR41) 2014; 5
H Ronkainen (3683_CR10) 2011; 30
Z Cao (3683_CR31) 2006; 78
JL Huppert (3683_CR35) 2007; 35
M Mempel (3683_CR44) 2003; 121
A Jukkola-Vuorinen (3683_CR19) 2009; 1
R Kulkarni (3683_CR11) 2011; 343
A Hidmark (3683_CR4) 2012
S Akira (3683_CR1) 2003; 85
SB Coffelt (3683_CR37) 2009; 7
A Trieu (3683_CR52) 2006; 26
J Korvala (3683_CR18) 2014; 43
A Marshak-Rothstein (3683_CR40) 2007; 25
G Weber (3683_CR51) 2009; 11
JM Silva (3683_CR48) 1999; 59
3683_CR49
J Eddy (3683_CR36) 2008; 36
AM Krieg (3683_CR43) 2012; 22
JH Kauppila (3683_CR16) 2011; 59
B Schmausser (3683_CR13) 2005; 295
MA Merrell (3683_CR15) 2006; 4
S Yoshizawa (3683_CR30) 1994; 22
D Droemann (3683_CR14) 2005; 6
JD Heilborn (3683_CR50) 2005; 114
J Tuomela (3683_CR21) 2012; 135
References_xml – volume: 11
  start-page: 306
  issue: 3
  year: 2012
  end-page: 318
  ident: CR46
  article-title: Cofactors required for TLR7- and TLR9-dependent innate immune responses
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2012.02.002
  contributor:
    fullname: Chanda
– ident: CR49
– volume: 121
  start-page: 511
  issue: 6
  year: 2013
  end-page: 522
  ident: CR25
  article-title: Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion
  publication-title: APMIS
  doi: 10.1111/apm.12016
  contributor:
    fullname: Selander
– volume: 67
  start-page: 774
  issue: 7
  year: 2007
  end-page: 781
  ident: CR12
  article-title: Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro
  publication-title: Prostate
  doi: 10.1002/pros.20562
  contributor:
    fullname: Selander
– volume: 43
  start-page: 530
  issue: 7
  year: 2014
  end-page: 537
  ident: CR18
  article-title: Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis
  publication-title: J Oral Pathol Med
  doi: 10.1111/jop.12160
  contributor:
    fullname: Salo
– year: 2013
  ident: CR28
  article-title: DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells
  publication-title: Breast Cancer Res Treat
  contributor:
    fullname: Selander
– volume: 279
  start-page: 17951
  issue: 17
  year: 2004
  end-page: 17956
  ident: CR29
  article-title: The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M311440200
  contributor:
    fullname: Belting
– volume: 136
  start-page: 521
  issue: 3
  year: 2004
  end-page: 526
  ident: CR8
  article-title: Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2004.02464.x
  contributor:
    fullname: Eck
– volume: 15
  start-page: 386
  issue: 3
  year: 2013
  end-page: 394
  ident: CR3
  article-title: Structural basis of innate immune recognition of viral RNA
  publication-title: Cell Microbiol
  doi: 10.1111/cmi.12061
  contributor:
    fullname: Modis
– volume: 48
  start-page: 319
  issue: 4
  year: 2009
  end-page: 325
  ident: CR32
  article-title: Selection for the G4 DNA motif at the 5′ end of human genes
  publication-title: Mol Carcinog
  doi: 10.1002/mc.20496
  contributor:
    fullname: Maizels
– year: 2010
  ident: CR20
  article-title: Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors
  publication-title: Cancer Sci
  contributor:
    fullname: Widschwendter
– volume: 11
  start-page: R6
  issue: 1
  year: 2009
  ident: CR51
  article-title: Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer
  publication-title: Breast Cancer Res
  doi: 10.1186/bcr2221
  contributor:
    fullname: Stahle
– volume: 59
  start-page: 643
  issue: 4
  year: 2011
  end-page: 649
  ident: CR16
  article-title: Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2011.03991.x
  contributor:
    fullname: Karttunen
– volume: 85
  start-page: 85
  issue: 2
  year: 2003
  end-page: 95
  ident: CR1
  article-title: Recognition of pathogen-associated molecular patterns by TLR family
  publication-title: Immunol Lett
  doi: 10.1016/S0165-2478(02)00228-6
  contributor:
    fullname: Hemmi
– volume: 6
  start-page: 1
  issue: 1
  year: 2005
  ident: CR14
  article-title: Human lung cancer cells express functionally active toll-like receptor 9
  publication-title: Respir Res
  doi: 10.1186/1465-9921-6-1
  contributor:
    fullname: Goldmann
– volume: 13
  start-page: 7663
  issue: 21
  year: 1985
  end-page: 7672
  ident: CR26
  article-title: Selective protection of in vitro synthesized cDNA against nucleases by incorporation of phosphorothioate-analogues
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/13.21.7663
  contributor:
    fullname: Neubert
– volume: 20
  start-page: 1003
  issue: 709–760
  year: 2002
  ident: CR27
  article-title: CpG motifs in bacterial DNA and their immune effects
  publication-title: Annu Rev Immunol
  contributor:
    fullname: Krieg
– year: 2011
  ident: CR5
  article-title: A novel toll-like receptor that recognizes vesicular stomatitis virus
  publication-title: J Biol Chem
  contributor:
    fullname: Zhang
– volume: 171
  start-page: 3154
  issue: 6
  year: 2003
  end-page: 3162
  ident: CR6
  article-title: Subcellular localization of Toll-like receptor 3 in human dendritic cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.6.3154
  contributor:
    fullname: Seya
– volume: 35
  start-page: 406
  issue: 2
  year: 2007
  end-page: 413
  ident: CR35
  article-title: G-quadruplexes in promoters throughout the human genome
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkl1057
  contributor:
    fullname: Balasubramanian
– volume: 5
  start-page: 200
  year: 2014
  ident: CR41
  article-title: Toll-like receptors in esophageal cancer
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2014.00200
  contributor:
    fullname: Selander
– volume: 36
  start-page: 1321
  issue: 4
  year: 2008
  end-page: 1333
  ident: CR36
  article-title: Conserved elements with potential to form polymorphic G-quadruplex structures in the first intron of human genes
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkm1138
  contributor:
    fullname: Maizels
– volume: 173
  start-page: 1179
  issue: 2
  year: 2004
  end-page: 1183
  ident: CR9
  article-title: TLR9 is localized in the endoplasmic reticulum prior to stimulation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.173.2.1179
  contributor:
    fullname: Segal
– volume: 1
  start-page: 59
  issue: 1
  year: 2009
  end-page: 68
  ident: CR19
  article-title: Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer
  publication-title: J Innate Immun
  doi: 10.1159/000151602
  contributor:
    fullname: Selander
– volume: 22
  start-page: 77
  issue: 2
  year: 2012
  end-page: 89
  ident: CR43
  article-title: CpG still rocks! Update on an accidental drug
  publication-title: Nucleic acid therapeutics
  contributor:
    fullname: Krieg
– volume: 278
  start-page: 836
  issue: 2
  year: 2003
  end-page: 842
  ident: CR47
  article-title: Massive telomere loss is an early event of DNA damage-induced apoptosis
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M206818200
  contributor:
    fullname: Blasco
– volume: 114
  start-page: 713
  issue: 5
  year: 2005
  end-page: 719
  ident: CR50
  article-title: Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells
  publication-title: Int J Cancer
  doi: 10.1002/ijc.20795
  contributor:
    fullname: Stahle
– volume: 121
  start-page: 1389
  issue: 6
  year: 2003
  end-page: 1396
  ident: CR44
  article-title: Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent
  publication-title: J Invest Dermatol
  doi: 10.1111/j.1523-1747.2003.12630.x
  contributor:
    fullname: Ollert
– volume: 4
  start-page: 437
  issue: 7
  year: 2006
  end-page: 447
  ident: CR15
  article-title: Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-06-0007
  contributor:
    fullname: Selander
– volume: 135
  start-page: 481
  issue: 2
  year: 2012
  end-page: 493
  ident: CR21
  article-title: Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-012-2181-7
  contributor:
    fullname: Selander
– volume: 279
  start-page: 19008
  issue: 18
  year: 2004
  end-page: 19017
  ident: CR7
  article-title: Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the toll-like receptors
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M311618200
  contributor:
    fullname: DeFranco
– volume: 26
  start-page: 527
  issue: 6
  year: 2006
  end-page: 544
  ident: CR52
  article-title: DNA motifs suppressing TLR9 responses
  publication-title: Crit Rev Immunol
  doi: 10.1615/CritRevImmunol.v26.i6.50
  contributor:
    fullname: Stacey
– year: 2012
  ident: CR4
  article-title: Cutting edge: TLR13 is a receptor for bacterial RNA
  publication-title: J Immunol
  contributor:
    fullname: Dalpke
– volume: 295
  start-page: 179
  issue: 3
  year: 2005
  end-page: 185
  ident: CR13
  article-title: Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with
  publication-title: Int J Med Microbiol
  doi: 10.1016/j.ijmm.2005.02.009
  contributor:
    fullname: Eck
– volume: 6
  start-page: 1
  year: 2005
  ident: CR42
  article-title: Human lung cancer cells express functionally active Toll-like receptor 9
  publication-title: Respir Res
  doi: 10.1186/1465-9921-6-1
  contributor:
    fullname: Goldmann
– ident: CR23
– volume: 70
  start-page: 817
  issue: 8
  year: 2010
  end-page: 824
  ident: CR17
  article-title: Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors
  publication-title: Prostate
  doi: 10.1002/pros.21115
  contributor:
    fullname: Vaarala
– volume: 34
  start-page: 3887
  issue: 14
  year: 2006
  end-page: 3896
  ident: CR33
  article-title: Gene function correlates with potential for G4 DNA formation in the human genome
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkl529
  contributor:
    fullname: Maizels
– volume: 30
  start-page: 84
  year: 2011
  ident: CR10
  article-title: Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/1756-9966-30-84
  contributor:
    fullname: Vaarala
– volume: 7
  start-page: 89
  year: 2014
  end-page: 101
  ident: CR22
  article-title: Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells
  publication-title: J Inflamm Res
  contributor:
    fullname: Malathi
– volume: 122
  start-page: 1030
  issue: 5
  year: 2008
  end-page: 1039
  ident: CR38
  article-title: Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion
  publication-title: Int J Cancer
  doi: 10.1002/ijc.23186
  contributor:
    fullname: Scandurro
– volume: 25
  start-page: 419
  year: 2007
  end-page: 441
  ident: CR40
  article-title: Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.22.012703.104514
  contributor:
    fullname: Rifkin
– volume: 26
  start-page: 55
  year: 2006
  end-page: 64
  ident: CR39
  article-title: Hypoxia and metastasis in breast cancer
  publication-title: Breast Dis
  contributor:
    fullname: Hill
– volume: 78
  start-page: 1478
  issue: 5
  year: 2006
  end-page: 1484
  ident: CR31
  article-title: Nuclease resistance of telomere-like oligonucleotides monitored in live cells by fluorescence anisotropy imaging
  publication-title: Anal Chem
  doi: 10.1021/ac0517601
  contributor:
    fullname: Tan
– volume: 25
  start-page: 381
  issue: 7
  year: 2004
  end-page: 386
  ident: CR2
  article-title: The immunobiology of the TLR9 subfamily
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2004.04.011
  contributor:
    fullname: Wagner
– volume: 6
  start-page: 1534
  issue: 10
  year: 2008
  end-page: 1543
  ident: CR24
  article-title: Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-07-2005
  contributor:
    fullname: Selander
– volume: 59
  start-page: 3251
  issue: 13
  year: 1999
  end-page: 3256
  ident: CR48
  article-title: Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations
  publication-title: Cancer Res
  contributor:
    fullname: Bonilla
– volume: 8
  start-page: 266
  issue: 1
  year: 2014
  end-page: 274
  ident: CR45
  article-title: Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro
  publication-title: Oncol Lett
  contributor:
    fullname: Selander
– volume: 343
  start-page: 141
  issue: 1
  year: 2011
  end-page: 152
  ident: CR11
  article-title: Insights into the role of Toll-like receptors in modulation of T cell responses
  publication-title: Cell Tissue Res
  doi: 10.1007/s00441-010-1017-1
  contributor:
    fullname: Sharif
– volume: 37
  start-page: 6716
  issue: 20
  year: 2009
  end-page: 6722
  ident: CR34
  article-title: Genome-wide analysis of a G-quadruplex-specific single-chain antibody that regulates gene expression
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkp740
  contributor:
    fullname: Balasubramanian
– volume: 22
  start-page: 2217
  issue: 12
  year: 1994
  end-page: 2221
  ident: CR30
  article-title: Nuclease resistance of an extraordinarily thermostable mini-hairpin DNA fragment, d(GCGAAGC) and its application to in vitro protein synthesis
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/22.12.2217
  contributor:
    fullname: Hirao
– volume: 7
  start-page: 907
  issue: 6
  year: 2009
  end-page: 915
  ident: CR37
  article-title: Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-08-0326
  contributor:
    fullname: Scandurro
– volume: 48
  start-page: 319
  issue: 4
  year: 2009
  ident: 3683_CR32
  publication-title: Mol Carcinog
  doi: 10.1002/mc.20496
  contributor:
    fullname: J Eddy
– volume: 22
  start-page: 2217
  issue: 12
  year: 1994
  ident: 3683_CR30
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/22.12.2217
  contributor:
    fullname: S Yoshizawa
– volume: 114
  start-page: 713
  issue: 5
  year: 2005
  ident: 3683_CR50
  publication-title: Int J Cancer
  doi: 10.1002/ijc.20795
  contributor:
    fullname: JD Heilborn
– volume: 30
  start-page: 84
  year: 2011
  ident: 3683_CR10
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/1756-9966-30-84
  contributor:
    fullname: H Ronkainen
– volume: 78
  start-page: 1478
  issue: 5
  year: 2006
  ident: 3683_CR31
  publication-title: Anal Chem
  doi: 10.1021/ac0517601
  contributor:
    fullname: Z Cao
– volume: 6
  start-page: 1534
  issue: 10
  year: 2008
  ident: 3683_CR24
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-07-2005
  contributor:
    fullname: JM Ilvesaro
– volume: 59
  start-page: 643
  issue: 4
  year: 2011
  ident: 3683_CR16
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2011.03991.x
  contributor:
    fullname: JH Kauppila
– volume: 43
  start-page: 530
  issue: 7
  year: 2014
  ident: 3683_CR18
  publication-title: J Oral Pathol Med
  doi: 10.1111/jop.12160
  contributor:
    fullname: J Korvala
– volume: 343
  start-page: 141
  issue: 1
  year: 2011
  ident: 3683_CR11
  publication-title: Cell Tissue Res
  doi: 10.1007/s00441-010-1017-1
  contributor:
    fullname: R Kulkarni
– volume: 37
  start-page: 6716
  issue: 20
  year: 2009
  ident: 3683_CR34
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkp740
  contributor:
    fullname: H Fernando
– volume: 67
  start-page: 774
  issue: 7
  year: 2007
  ident: 3683_CR12
  publication-title: Prostate
  doi: 10.1002/pros.20562
  contributor:
    fullname: JM Ilvesaro
– volume: 7
  start-page: 89
  year: 2014
  ident: 3683_CR22
  publication-title: J Inflamm Res
  doi: 10.2147/JIR.S61365
  contributor:
    fullname: S Mukherjee
– volume: 20
  start-page: 1003
  issue: 709–760
  year: 2002
  ident: 3683_CR27
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.20.100301.06484201.064842
  contributor:
    fullname: AM Krieg
– volume: 171
  start-page: 3154
  issue: 6
  year: 2003
  ident: 3683_CR6
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.6.3154
  contributor:
    fullname: M Matsumoto
– volume: 26
  start-page: 55
  year: 2006
  ident: 3683_CR39
  publication-title: Breast Dis
  doi: 10.3233/BD-2007-26105
  contributor:
    fullname: N Chaudary
– volume: 279
  start-page: 19008
  issue: 18
  year: 2004
  ident: 3683_CR7
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M311618200
  contributor:
    fullname: T Nishiya
– volume: 135
  start-page: 481
  issue: 2
  year: 2012
  ident: 3683_CR21
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-012-2181-7
  contributor:
    fullname: J Tuomela
– volume: 121
  start-page: 511
  issue: 6
  year: 2013
  ident: 3683_CR25
  publication-title: APMIS
  doi: 10.1111/apm.12016
  contributor:
    fullname: JH Kauppila
– volume: 6
  start-page: 1
  year: 2005
  ident: 3683_CR42
  publication-title: Respir Res
  doi: 10.1186/1465-9921-6-1
  contributor:
    fullname: D Droemann
– volume: 7
  start-page: 907
  issue: 6
  year: 2009
  ident: 3683_CR37
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-08-0326
  contributor:
    fullname: SB Coffelt
– volume: 70
  start-page: 817
  issue: 8
  year: 2010
  ident: 3683_CR17
  publication-title: Prostate
  doi: 10.1002/pros.21115
  contributor:
    fullname: MR Vaisanen
– volume: 35
  start-page: 406
  issue: 2
  year: 2007
  ident: 3683_CR35
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkl1057
  contributor:
    fullname: JL Huppert
– volume: 278
  start-page: 836
  issue: 2
  year: 2003
  ident: 3683_CR47
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M206818200
  contributor:
    fullname: R Ramirez
– ident: 3683_CR23
  doi: 10.1016/j.urolonc.2014.09.016
– volume: 173
  start-page: 1179
  issue: 2
  year: 2004
  ident: 3683_CR9
  publication-title: J Immunol
  doi: 10.4049/jimmunol.173.2.1179
  contributor:
    fullname: CA Leifer
– ident: 3683_CR49
  doi: 10.4049/jimmunol.0902305
– volume: 36
  start-page: 1321
  issue: 4
  year: 2008
  ident: 3683_CR36
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkm1138
  contributor:
    fullname: J Eddy
– year: 2012
  ident: 3683_CR4
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1200898
  contributor:
    fullname: A Hidmark
– volume: 15
  start-page: 386
  issue: 3
  year: 2013
  ident: 3683_CR3
  publication-title: Cell Microbiol
  doi: 10.1111/cmi.12061
  contributor:
    fullname: IC Berke
– volume: 1
  start-page: 59
  issue: 1
  year: 2009
  ident: 3683_CR19
  publication-title: J Innate Immun
  doi: 10.1159/000151602
  contributor:
    fullname: A Jukkola-Vuorinen
– volume: 11
  start-page: 306
  issue: 3
  year: 2012
  ident: 3683_CR46
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2012.02.002
  contributor:
    fullname: CY Chiang
– volume: 6
  start-page: 1
  issue: 1
  year: 2005
  ident: 3683_CR14
  publication-title: Respir Res
  doi: 10.1186/1465-9921-6-1
  contributor:
    fullname: D Droemann
– year: 2011
  ident: 3683_CR5
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.159590
  contributor:
    fullname: Z Shi
– volume: 59
  start-page: 3251
  issue: 13
  year: 1999
  ident: 3683_CR48
  publication-title: Cancer Res
  contributor:
    fullname: JM Silva
– volume: 85
  start-page: 85
  issue: 2
  year: 2003
  ident: 3683_CR1
  publication-title: Immunol Lett
  doi: 10.1016/S0165-2478(02)00228-6
  contributor:
    fullname: S Akira
– volume: 279
  start-page: 17951
  issue: 17
  year: 2004
  ident: 3683_CR29
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M311440200
  contributor:
    fullname: S Sandgren
– volume: 4
  start-page: 437
  issue: 7
  year: 2006
  ident: 3683_CR15
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-06-0007
  contributor:
    fullname: MA Merrell
– volume: 26
  start-page: 527
  issue: 6
  year: 2006
  ident: 3683_CR52
  publication-title: Crit Rev Immunol
  doi: 10.1615/CritRevImmunol.v26.i6.50
  contributor:
    fullname: A Trieu
– volume: 8
  start-page: 266
  issue: 1
  year: 2014
  ident: 3683_CR45
  publication-title: Oncol Lett
  doi: 10.3892/ol.2014.2095
  contributor:
    fullname: J Sandholm
– volume: 136
  start-page: 521
  issue: 3
  year: 2004
  ident: 3683_CR8
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2004.02464.x
  contributor:
    fullname: B Schmausser
– volume: 11
  start-page: R6
  issue: 1
  year: 2009
  ident: 3683_CR51
  publication-title: Breast Cancer Res
  doi: 10.1186/bcr2221
  contributor:
    fullname: G Weber
– volume: 22
  start-page: 77
  issue: 2
  year: 2012
  ident: 3683_CR43
  publication-title: Nucleic acid therapeutics
  doi: 10.1089/nat.2012.0340
  contributor:
    fullname: AM Krieg
– volume: 25
  start-page: 381
  issue: 7
  year: 2004
  ident: 3683_CR2
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2004.04.011
  contributor:
    fullname: H Wagner
– volume: 25
  start-page: 419
  year: 2007
  ident: 3683_CR40
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.22.012703.104514
  contributor:
    fullname: A Marshak-Rothstein
– volume: 295
  start-page: 179
  issue: 3
  year: 2005
  ident: 3683_CR13
  publication-title: Int J Med Microbiol
  doi: 10.1016/j.ijmm.2005.02.009
  contributor:
    fullname: B Schmausser
– year: 2010
  ident: 3683_CR20
  publication-title: Cancer Sci
  doi: 10.1111/j.1349-7006.2010.01491.x
  contributor:
    fullname: R Berger
– year: 2013
  ident: 3683_CR28
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-013-2762-0
  contributor:
    fullname: J Tuomela
– volume: 5
  start-page: 200
  year: 2014
  ident: 3683_CR41
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2014.00200
  contributor:
    fullname: JH Kauppila
– volume: 34
  start-page: 3887
  issue: 14
  year: 2006
  ident: 3683_CR33
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkl529
  contributor:
    fullname: J Eddy
– volume: 121
  start-page: 1389
  issue: 6
  year: 2003
  ident: 3683_CR44
  publication-title: J Invest Dermatol
  doi: 10.1111/j.1523-1747.2003.12630.x
  contributor:
    fullname: M Mempel
– volume: 13
  start-page: 7663
  issue: 21
  year: 1985
  ident: 3683_CR26
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/13.21.7663
  contributor:
    fullname: G Schreiber
– volume: 122
  start-page: 1030
  issue: 5
  year: 2008
  ident: 3683_CR38
  publication-title: Int J Cancer
  doi: 10.1002/ijc.23186
  contributor:
    fullname: SB Coffelt
SSID ssj0009709
Score 2.3065922
Snippet Toll-like receptor 9 (TLR9) is a cellular DNA-receptor widely expressed in cancers. We previously showed that synthetic and self-derived DNA fragments induce...
SourceID proquest
gale
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 261
SubjectTerms Antimicrobial Cationic Peptides - genetics
Breast cancer
Breast Neoplasms - genetics
Breast Neoplasms - pathology
Cancer cells
Cancer genetics
Cancer research
Cancer therapies
Cell adhesion & migration
Cell Line, Tumor
Chemotherapy
Deoxyribonucleic acid
DNA
DNA Fragmentation
DNA, Neoplasm - genetics
Female
G-Quadruplexes
Genetic research
Humans
Ligands
Medicine
Medicine & Public Health
Neoplasm Invasiveness - genetics
Neoplasm Invasiveness - pathology
Oncology
Preclinical Study
Proteases
Protein expression
RNA
RNA, Messenger - genetics
Telomere - genetics
Toll-Like Receptor 9 - genetics
SummonAdditionalLinks – databaseName: SpringerLINK - Czech Republic Consortium
  dbid: AGYKE
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Zb9QwELZKKyFeKDdbChgJCQnkVeIzeVxBD8G2D2grlafIsZ2qapUtaVIhHvjtzOTY7pZD6luUTC57Ts_MZ0LeFioFtR95poTnTDpvWJobw7wQQmqZcJfjesfBod4_kp-P1fEa4Yuli_JsPGQkW0W91OsGoQxEvpoJnQim7pANMD0ojBuTvW9fdq6hdk1X2IGI3jqJ9JDL_NtDVqzRTZ28ZJRuZElb47O72TUEXraYhVhzcjZu6nzsfv6J6HiL_3pA7ve-KJ10zPOQrIXyEbl70GfbH5Nfs3A-bzM6dI99b6yvmovz8IOhnwuvoJ8OJ7So7EnbJUchuAc2obPp15S1_Sjgy1Jbejqdgn5hVbfpPZw7La8srtHBAc2xJr6mDnmvophFwAfRq9O6mj8hR7s7s4_7rN-vgTllRM0Syy14BByCylSEPMKGrhj0ZxJUCn6O55GLlYPpFz4ucmcCWEanrAycp7GHYPkpWS_nZXhOaDCxK0xIlSvgRhPnguceoXlUobUKekTeD_OWXXSwHNk1ADOOaIalaziimRqR1zizWddZuhDpbCIh9koRgn9E3rUUKNR1ZZ3texPgYxAea4Vye4UShNGtXh64J-uVwWUWGx0ZziNpRuTN4jLeiQVuZZg3LU0sVZpI9T8aIxIBLj7QPOs4c_HzXOPmFAre8GFgs6UP-NfIbN2K-gW5x5FP2wWobbJeV014CS5Znb_qZfA3QxEogw
  priority: 102
  providerName: Springer Nature
Title Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro
URI https://link.springer.com/article/10.1007/s10549-016-3683-5
https://www.ncbi.nlm.nih.gov/pubmed/26780557
https://www.proquest.com/docview/1760722047
https://search.proquest.com/docview/1761459845
https://search.proquest.com/docview/1773830805
Volume 155
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1da9swUKwtjL2M7jtrl2kwGGyI2ZIlWU_D69KWLQ2jJJA9GVuSR6HYqeuUPe237852kqawPtnYZ0fxne77g5D3hTTA9gPHpHCcRdZpZnKtmRNCRCqKuc3R33E2Uaez6PtcznuH23WfVrniiS2jdpVFH_nnUKtAcx5E-sviiuHUKIyu9iM0dsheiIIOK8WPNikeRncpHtjbW8WBWkU1u9I5sIzAkFZMqFgwuSWX7nLnW-LpTry0FUPH--Rxrz_SpEP4E_LAl0_Jw7M-Qv6M_J36y6qNwtATdrXMXL1cXPo_DHVTeCH9NkloUWe_28o2CgY5oJZOx-eGtTUkoH_SrHR0PAaewOpuUD1cuyhvMvSrwQnNMY-9oRbppabo-ccX0ZuLpq6ek9nxaHp0yvoZC8xKLRoWZzwDKc7BEDTC5wEWYYXA82IvDegmjgc2lBZQJlxY5FZ7kGZWZpHn3IQODNwXZLesSv-KUK9DW2hvpC3gQR3mgucO2-nIQinp1YB8XH3hdNG10kg3TZMRHSmmmyE6UjkgbxEHaVcNut6GaRKBvWSwbf6AfGghcCM2dWazvp4AFoMtrbYgD7cgYQPZ7dsrPKf9Br5ON-Q2IO_Wt_FJTEorfbVsYcJImjiS98FoEQtQywHmZUdD6z_PFQ6UkPALn1ZEdWsB__syr-9f7gF5xJGqWy_RIdlt6qV_A3pTkw_Jjp7rYbtFhmQvOfn1YwTHr6PJz3O4OuPJPzFbFMU
link.rule.ids 314,780,784,12056,12223,21388,27924,27925,31719,31720,33266,33267,33744,33745,41081,41523,42150,42592,43310,43579,43805,52111,52234,73745,74014,74302
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3bbtMw1IJOgr0g7nQMZiQkJJBFYsd28oQKbBRIKzR10t6sxHbQpCnpsnTiiW_nnFzadRJ7q5qT1M253wl5W8gExH7gmBSOs8g6zZJca-aEEJGKYm5zjHfM5mp6Ev04lad9wO2yL6scZGIrqF1lMUb-MdQq0JwHkf60vGC4NQqzq_0KjbtkByenyxHZ-Xw4_3W8GburuyIPnO6t4kANec2ueQ58I3ClFRMqFkxuaaab8vmagrqRMW0V0dFD8qC3IOmkQ_kjcseXj8m9WZ8jf0L-Lvx51eZh6Dd2scpcvVqe-z8MrVN4IP06n9Cizn63vW0UXHJALl2kxwlru0jAAqVZ6WiaglRgdbeqHr47K68yjKzBB5pjJXtDLVJMTTH2jw-iV2dNXT0lJ0eHiy9T1m9ZYFZq0bA44xnocQ6uYCJ8HmAbVghSL_YyAevE8cCG0gLShAuL3GoP-szKLPKcJ6EDF_cZGZVV6V8Q6nVoC-0TaQu4UYe54LnDgTqyUEp6NSbvhzdslt0wDbMZm4zoMFhwhugwckwOEAem6wddM6KZROAxJTg4f0zetRDIik2d2azvKIDD4FCrLcj9LUhgIbt9ecCz6Vn40mwIbkzerC_jnViWVvpq1cKEkUziSN4Go0UswDAHmOcdDa3_PFe4UkLCL3wYiOraAf73ZvZuP-4BuT9dzFKTfp__fEl2OVJ4GzPaJ6OmXvlXYEU1-eueVf4BLyQUVQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1Na9swVHQplF3GvputazUYDDZEbcmS7NPI2qbdloZSUujN2JI8CsVOXafstN--92w5aQrrzdjPtuz3rfdFyKdCJiD2A8uksJxFxmqW5FozK4SIVBRzk-N-x-lUnVxEPy_lpc9_uvVplb1MbAW1rQzuke-HWgWa8yDS-4VPizg7HH-b3zCcIIWRVj9O4wnZBK0Y8AHZ_H40PTtfteDVXcIHdvpWcaD6GGdXSAd-ErjVigkVCybXtNRDWX1PWT2InrZKafycPPPWJB116H9BNlz5kmyd-nj5K_J35q6rNiZDj9nNIrP1Yn7t_jC0VOGB9HA6okWd_W7r3Ci454BoOpucJ6ytKAFrlGalpZMJSAhWd2Pr4dxVeZfhLhsc0Byz2htqkHpqinEAfBC9u2rq6jW5GB_NDk6Yn7jAjNSiYXHGM9DpHNzCRLg8wJKsECRg7GQClorlgQmlAQQKGxa50Q50m5FZ5DhPQgvu7hsyKKvSbRPqdGgK7RJpCrhRh7ngucXmOrJQSjo1JF_6P5zOu8Ya6aqFMqIjxeQzREcqh2QPcZB2taFLpkxHEXhPCTbRH5LPLQSyZVNnJvPVBbAYbHC1BrmzBgnsZNYv93hOPTvfpiviG5KPy8t4J6aola5atDBhJJM4ko_BaBELMNIB5m1HQ8uP5wrHS0h4w9eeqO4t4H9_5t3jy90jW8Al6eTH9Nd78pQjgbfbRztk0NQL9wEMqibf9ZzyD3EyGII
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Telomeric+G-quadruplex-forming+DNA+fragments+induce+TLR9-mediated+and+LL-37-regulated+invasion+in+breast+cancer+cells+in+vitro&rft.jtitle=Breast+cancer+research+and+treatment&rft.au=Tuomela%2C+Johanna+M&rft.au=Sandholm%2C+Jouko+A&rft.au=Kaakinen%2C+Mika&rft.au=Hayden%2C+Katherine+L&rft.date=2016-01-01&rft.eissn=1573-7217&rft.volume=155&rft.issue=2&rft.spage=261&rft_id=info:doi/10.1007%2Fs10549-016-3683-5&rft_id=info%3Apmid%2F26780557&rft.externalDocID=26780557
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-6806&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-6806&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-6806&client=summon